Genialis Expands into Triple-Negative Breast Cancer Research: Insights from SABCS 2023
Breast cancer remains a challenging therapeutic area in oncology, [...]
Breast cancer remains a challenging therapeutic area in oncology, [...]
To build a great company, and a great business, [...]
Genialis recently took part in two pivotal conferences in [...]
The Xerna TME panel identified nearly 50 percent of [...]
This study explores the distribution of genomic alterations in [...]
This study introduces a machine learning model that uses [...]
Welcome to Talking Precision Medicine (TPM podcast) — the [...]
Partnership provides high-quality and clinically relevant data for modeling [...]
Genialis points ResponderID, its innovative biomarker framework combining machine [...]
Traditional biomarkers often fail to capture the dynamic nature [...]